Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1. This appears to be a minor update with no visible changes to page content or layout.SummaryDifference0.0%

- Check13 days agoChange DetectedA new note in the Publications section explains that items are automatically filled from PubMed and may not be about the study. The page now shows Revision: v3.3.1 and includes the advisory text: 'To avoid being alerted by small changes, set an alert condition by clicking below.'SummaryDifference0.1%

- Check20 days agoChange DetectedThe Taiwan site listing was updated: 'Tainan City, Taiwan, 70403' was removed and replaced with 'Tainan, Taiwan, 70403'.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded a new PubMed-sourced publication entry under Publications for a 2025 ALLIANCE-related paper by D'Antoni ML et al. The entry includes the citation and a From PubMed note.SummaryDifference0.4%

- Check63 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

- Check70 days agoChange DetectedUpgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.